Personalized Tacrolimus Dose Requirement by CYP3A5 but Not ABCB1 or ACE Genotyping in Both Recipient and Donor after Pediatric Liver Transplantation-Reference-Cited by-同舟云学术

Personalized Tacrolimus Dose Requirement by CYP3A5 but Not ABCB1 or ACE Genotyping in Both Recipient and Donor after Pediatric Liver Transplantation

Published:2014-10-13 Issue:10 Volume:9 Page:e109464
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chen Yi-kuan,Han Long-zhi,Xue Feng,Shen Cong-huan,Lu Jun,Yang Tai-hua,Zhang Jian-jun,Xia Qiang

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials;L Penninga;Eur J Clin Pharmacol,2010

2. Effect of age, ethnicity, and glucocorticoid use on tacrolimus pharmacokinetics in pediatric renal transplant patients;JS Kim;Pediatr Transplant,2005

3. The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients;A Provenzani;Ann Transplant,2009

4. Standard dosing of tacrolimus leads to overexposure in pediatric renal transplantation recipients;JY Kausman;Pediatr Transplant,2008

5. Influence of CYP3A5 polymorphism on tacrolimus maintenance doses and serum levels after renal transplantation: age dependency and pharmacological interaction with steroids;JR Ferraris;Pediatr Transplant,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pattern of CYP3A5 and MDR-1 single-nucleotide polymorphism and its impact on Tacrolimus levels and clinical outcomes in living renal allograft recipient;RPS Pharmacy and Pharmacology Reports;2024-04-01

2. A longitudinal study of long‐term renal outcome after pediatric liver transplantation in relation to CNI exposure;Pediatric Transplantation;2023-12-27

3. GRWR Correlates with the Metabolism of Tacrolimus after Pediatric Living Donor Liver Transplantation According to Donor CYP3A5 Polymorphism;BioMed Research International;2022-10-30

4. Compare the performance of multiple machine learning models in predicting tacrolimus concentration for infant patients with living donor liver transplantation;Pediatric Transplantation;2022-08-30

5. The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review;Pharmacogenomics and Personalized Medicine;2022-06